Ascendis Pharma A/S (BVMF:A1SN34)
70.21
-1.26 (-1.76%)
At close: Nov 4, 2025
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of 64.97 billion as of December 4, 2025. Its market cap has increased by 54.98% in one year.
Market Cap
64.97B
Enterprise Value
66.67B
Revenue
4.04B
Ranking
n/a
PE Ratio
n/a
Stock Price
70.21
Market Cap Chart
Since January 28, 2015, Ascendis Pharma's market cap has increased from 1.07B to 64.97B, an increase of 5,977.33%. That is a compound annual growth rate of 45.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 67.53B | 32.61% |
| Dec 31, 2024 | 50.92B | 47.30% |
| Dec 29, 2023 | 34.57B | -4.17% |
| Dec 30, 2022 | 36.07B | -15.20% |
| Dec 31, 2021 | 42.54B | -9.05% |
| Dec 31, 2020 | 46.78B | 75.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 101.09B |
| Raia Drogasil | 41.21B |
| Hypera | 16.96B |
| Fleury | 8.28B |
| Odontoprev | 6.42B |
| Diagnósticos da América | 4.31B |
| Empreendimentos Pague Menos | 4.01B |
| Blau Farmacêutica | 2.38B |